Список литературы

1. Бржезовский В.Ж. Опухоли щитовидной железы. В кн.: А.И. Пачес и др. Опухоли головы и шеи. 5-е изд., доп. и перераб. М.: Практическая медицина, 2013. С. 339 - 359

2. Диагностика и лечение медуллярного рака щитовидной железы. Национальные клинические рекомендации. Опухоли головы и шеи. 2013; (4): 36 - 45

3. Газизова Д.О., Бельцевич Д.Г. Современный взгляд на проблему диагностики и лечения медуллярного рака щитовидной железы. Эндокринная хирургия 2013; (3): 4 - 21

4. Wells S.A. Revised American Thyroid Association Guidelines for the Management of MTC (2015). Thyroid 2015; 25(6): 567 - 610

5. Howlader N., Noone A.M., Krapcho M. et al. (eds). SEER Cancer Statistics Review, 1975 - 2014, National Cancer Institute. Available at: https://seer.cancer.gov/csr/1975_2014

6. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Thyroid Carcinoma. Version 2. 2019

7. Allelein, S., Ehlers, M., Morneau, C. (2017). Measurement of Basal Serum Calcitonin for the Diagnosis of Medullary Thyroid Cancer. Hormone and Metabolic Research, 50(01), 23 - 28

8. Costante G., Meringolo D., Durante C. et al. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 2007; 92: 450 - 5

9. Basuyau, J.-P. (2004). Reference Intervals for Serum Calcitonin in Men, Women, and Children. Clinical Chemistry, 50(10), 1828 - 1830. doi: 10.1373/clinchem.2003.026963

10. Yocum M.W., Butterfield J.H., Gharib H. Increased plasma calcitonin levels in systemic mast cell disease. Mayo Clin Proc 1994; 69: 987 - 90

11. Schuetz M., Duan H., Wahl K. et al. T lymphocyte cytokine production patterns in Hashimoto patients with elevated calcitonin levels and their relationship to tumor initiation. Anticancer Res 2006; 26: 4591 - 6

12. Boi F., Maurelli I., Pinna G. et al. Calcitonin measurement in wash-out fluid from fine needle aspiration of neck masses in patients with primary and metastatic medullary thyroid carcinoma. J Clin Endocrinol Metab 2007; 92: 2115 - 8

13. Kudo T., Miyauchi A., Ito Y. et al. Diagnosis of medullary thyroid carcinoma by calcitonin measurement in fine-needle aspiration biopsy specimens. Thyroid 2007; 17: 635 - 8

14. Elisei R., Cosci B., Romei C. et al. Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J Clin Endocrinol Metab 2008; 93: 682 - 7

15. Alexander E.K., Cooper D. The importance, and important limitations, of ultrasound imaging for evaluating thyroid nodules. JAMA Intern Med 2013; 173: 1796 - 7

16. Friedrich-Rust M., Meyer G., Dauth N. et al. Interobserver agreement of Thyroid Imaging Reporting and Data System (TIRADS) and strain elastography for the assessment of thyroid nodules. PLoS One 2013; 8: e77927

17. Roy, M., Chen, H., & Sippel, R.S. (2013). Current Understanding and Management of Medullary Thyroid Cancer. The Oncologist, 18(10), 1093 - 1100

18. Trimboli, P., Castellana, M., Virili, C., Giorgino, F., & Giovanella, L. (2018). Efficacy of Vandetanib in Treating Locally Advanced or Metastatic Medullary Thyroid Carcinoma According to RECIST Criteria: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology

19. Elisei R., Schlumberger M.J., Muller S.P. et al. Cabozantinib in progressive medullary thyroid cancer. J Clin Oncol 2013; 31: 3639 - 46

20. Terezakis S.A., Lee N.Y. The role of radiation therapy in the treatment of medullary thyroid cancer. J Natl Compr Canc Netw 2010; 8: 532 - 40

21. Vitale G., Fonderico F., Martignetti A. et al. Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer. Br J Cancer 2001; 84: 1586 - 90

22. Kim I.Y., Kondziolka D., Niranjan A. Gamma knife radiosurgery for metastatic brain tumors from thyroid cancer. J Neurooncol 2009; 93: 355 - 9

23. Borcek P., Asa S.L., Gentili F. et al. Brain metastasis from medullary thyroid carcinoma. BMJ Case Rep 2010; pii: bcr0920103301

24. Tavares M.R., Toledo S.P., Montenegro F.L., et al. Surgical approach to medullary thyroid carcinoma associated with multiple endocrine neoplasia type 2. Clinics (Sao Paulo). 2012; 67 Suppl 1(Suppl 1): 149 - 154. doi: 10.6061/clinics/2012(sup01)25

25. Mathiesen, J.S., Kroustrup, J.P., Vestergaard, P., et al. (2019). Survival and long-term biochemical cure in medullary thyroid carcinoma in Denmark 1997 - 2014: A nationwide study. Thyroid

26. Pellegriti, G., Leboulleux, S., Baudin, E. et al. Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging. Br J Cancer 88, 1537 - 1542 (2003)

27. Barbet J., Campion L., Kraeber-Bodere F., Chatal J.F. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 2005; 90: 6077 - 84